CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS Eşleşti

Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme

Journal of Drug Delivery Science and Technology · Haziran 2020

YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme
Journal of Drug Delivery Science and Technology · 2020 SCI-Expanded
DOKTOR ÖĞRETİM ÜYESİ SEMA ARISOY →

Makale Bilgileri

DergiJournal of Drug Delivery Science and Technology
Yayın TarihiHaziran 2020
Cilt / Sayfa57
Özet With its ability to cross the blood-brain barrier, temozolomide (TMZ) is the first-line treatment option in glioblastoma multiforme therapy. This study aims to design TMZ-loaded PLGA nanoparticles (TMZ-PLGA-NP) in a thermoreversible hydrogel system comprising Pluronic® F-127. TMZ-PLGA-NP were prepared via emulsion-solvent evaporation method using dimethylformamide (DMF) as organic solvent and PVA solution as stabilizer. Experimental parameters for the formulation process and in vitro release profiles of free drug, TMZ-PLGA-NP and TMZ-PLGA-NP-loaded in hydrogel were investigated. Particle size in the range of 100–200 nm with an encapsulation efficiency of 55–70% has been obtained. In vitro studies showed that the TMZ-PLGA-NP loaded in hydrogel formulations have significantly slowed down the release process, providing controlled and sustained release. These nanoparticles were efficiently taken up by the glioblastoma cells and the TMZ released from the TMZ-PLGA-NP-loaded in hydrogel could reach to the efficiency of direct exposure to the free-drug. In conclusion, the thermoreversible hydrogel system containing TMZ-loaded PLGA nanoparticles may serve as a promising approach that could sustain long-term drug release for the treatment of residual glial tumors after surgery.

Yazarlar (5)

1
Ozgun Sayiner
2
Sema Arisoy
ORCID: 0000-0003-2798-1884
3
Tansel Comoglu
ORCID: 0000-0002-4221-5814
4
Feyza Gul Ozbay
5
Gunes Esendagli

Anahtar Kelimeler

Brain delivery Glioblastoma multiforme Hydrogel Nanoparticle Temozolomide Thermoreversible

Kurumlar

Ankara Üniversitesi
Ankara Turkey
Hacettepe Üniversitesi
Ankara Turkey
Inönü Üniversitesi
Malatya Turkey

Metrikler

25
Atıf
5
Yazar
6
Anahtar Kelime